| Symbol: |
WASL
|
| Description: |
Wiskott-Aldrich syndrome-like [Source:HGNC Symbol;Acc:12735]
|
| Location: |
Chr7:123321989-123389121[-]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:437
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| WASL |
NSC 406433 |
0.011 |
Up |
| WASL |
Morpholine-N-dithiocarbamate |
0.01 |
Up |
| WASL |
Neocuproin |
0.048 |
Up |
| WASL |
NSC 57958 |
0.026 |
Up |
| WASL |
Camptothecin ethylglycinate ester hydrochloride |
0.01 |
Up |
| WASL |
RAPAMYCIN PRODRUG |
0.033 |
Up |
| WASL |
NSC 607281 |
0.013 |
Up |
| WASL |
Camptothecin hemisuccinate sodium salt |
0.012 |
Up |
| WASL |
Camptothecin lysinate HCl |
0.007 |
Up |
| WASL |
NSC 611074 |
0.001 |
Up |
| WASL |
NSC 611274 |
0.007 |
Down |
| WASL |
1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride |
0.009 |
Up |
| WASL |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.001 |
Up |
| WASL |
3-Deazaneplanocin, hydrochloride |
0.001 |
Up |
| WASL |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.045 |
Down |
Expression pattern: Sensitivity / Resistance
Total:30 Current:6
First Prev Next Last 
|
| SNP:
~ Export ~
|
Records:60
Total:4 Current:1
[First] [Prev]  Next Last 
|
| miRNA:
~ Export ~
|
Records:2
| Gene |
Gen_transcript |
miRNA |
miR_location |
| WASL |
ENST00000223023 |
hsa-mir-142-3p |
Chr17:56408606-56408628[-] |
| WASL |
ENST00000223023 |
hsa-mir-214-3p |
Chr1:172107956-172107977[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|